Medicine & TechnologyIn a historic announcement by the Africa Regional Certification Commission during a World Health Organization (WHO) event has declared Africa free from wild polio, with the continent's last case recorded four years ago in Nigeria.
An antibody developed during the time of SARS helped researchers from MassBiologics find another antibody that is effective in fighting coronavirus. The unique IgA antibody may be used to develop an effective vaccine.
The current case count in the U.S. is only getting worse with 1,000 deaths per day, with up to 200,000 deaths forecasted by September. At this rate and with the country's obesity epidemic, herd immunity is not an option and would only result in a massive death count.
The Gamaleya vaccine is the first the receive regulatory approval in the world after two months of testing. Scientists around the world are skeptic, including the Association of Clinical Trials Organizations, of its efficacy and safety.
The FDA 'Fast Track' designation may not be as safe as people may believe, warns a medical expert. The cost the people may be paying for vaccines may be a permanent alternation in their DNA.
Moderna, the biotech company just signed a big cloud deal with Amazon Web Services that will provide its standard platform for doing analytics and machine learning as they continue to develop COVID-19 vaccines.
Dr. Anthony Fauci says a virus will be available by next year the earliest and urges politicians to shut down states again. Meanwhile, the CDC announces lingering symptoms in young adults while urging schools to reopen by fall.
Scientists from Sechenov University said they have already finished human trials for a coronavirus vaccine and results have proven the medication's effectiveness. But there are no reports yet on its commercial reproduction.
The United States has invested $42 million into producing syringes and needles in anticipation of the future coronavirus vaccine. The US President is hopeful that a vaccine could be ready by the end of the year or early next year.
Scientists recreate human cell membranes onto an electronic chip to measure its behavior with external substances such as viruses and antibiotics. Soon, it will be screening drug candidates for coronavirus.
The relationship between blood platelets and viral infection is clarified in a recent study. Further research is needed to see how platelets help the immune system fight viruses such as COVID-19, and how these findings may help with vaccine developments.
Inovio is the only company championing genetic vaccines and other coronavirus vaccine developments, leading to what may be a breakthrough for DNA vaccines.
As companies selected in the Operation Warp Speed program race in developing a coronavirus vaccine, the FDA released basic guidelines the ensure that it is clinically safe.
Dr. Fauci recognizes the need for more education about vaccines with only 66% of America willing to get vaccinated and that a 70% - 75% protective vaccine against coronavirus would suffice.
A reverse genetics system was used to create and study a mutant version of the highly contagious rotavirus. The initial steps of viral assembly gave valuable insight on what may trigger virus multiplication.